Thomas J. Herzfeld Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,239
Closed -$62K – 333
2022
Q2
$62K Buy
1,239
+150
+14% +$7.96K 0.03% 106
2022
Q1
$56K Sell
1,089
-278
-20% -$14.4K 0.02% 119
2021
Q4
$68K Buy
1,367
+328
+32% +$16.2K 0.02% 131
2021
Q3
$50K Buy
1,039
+156
+18% +$7.93K 0.02% 133
2021
Q2
$46K Buy
883
+106
+14% +$5.53K 0.02% 150
2021
Q1
$38K Buy
+777
New +$37.3K 0.02% 164
2020
Q2
– Sell
-162
Closed -$7K – 329
2020
Q1
$7K Buy
162
+27
+20% +$1.29K ﹤0.01% 195
2019
Q4
$7K Hold
135
– – ﹤0.01% 221
2019
Q3
$6K Hold
135
– – ﹤0.01% 240
2019
Q2
$6K Sell
135
-112
-45% -$4.76K ﹤0.01% 250
2019
Q1
$11K Buy
247
+74
+43% +$3.17K ﹤0.01% 235
2018
Q4
$8K Hold
173
– – ﹤0.01% 242
2018
Q3
$8K Hold
173
– – ﹤0.01% 239
2018
Q2
$7K Sell
173
-13
-7% -$512 ﹤0.01% 269
2018
Q1
$7K Hold
186
– – ﹤0.01% 285
2017
Q4
$8K Sell
186
-6
-3% -$277 ﹤0.01% 287
2017
Q3
$10K Hold
192
– – ﹤0.01% 251
2017
Q2
$9K Sell
192
-490
-72% -$23.4K ﹤0.01% 251
2017
Q1
$31K Buy
682
+70
+11% +$2.97K 0.01% 243
2016
Q4
$25K Hold
612
– – 0.01% 261
2016
Q3
$23K Hold
612
– – 0.01% 259
2016
Q2
$26K Buy
+612
New +$25.1K 0.01% 256

Other funds holding SNY

Thomas J. Herzfeld Advisors's SNY Position: Q3 2022 in Review

Thomas J. Herzfeld Advisors sold out of Sanofi (SNY) in Q3 2022, closing a stake of 1,239 shares — an estimated $62K sold.

Thomas J. Herzfeld Advisors first reported a position in SNY in Q2 2016 and held it in 22 quarters. The position peaked at $68K in Q4 2021. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Thomas J. Herzfeld Advisors reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 1,239 Sanofi shares in Q3 2022, an estimated $62K.
  • Thomas J. Herzfeld Advisors first reported a position in Sanofi in Q2 2016 and held it in 22 quarters.
  • Thomas J. Herzfeld Advisors's Sanofi position peaked at $68K in Q4 2021.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.